May 4, 2017 10:00 AM EDT
People
Discovery

Se­r­i­al start­up sci­en­tist Ronald Evans tests a new Mighty Mouse drug, mak­ing marathon run­ners with a pill

John Carroll

Editor & Founder

Salk In­sti­tute’s leg­endary sci­en­tist Ronald Evans has co-found­ed a string of new biotech com­pa­nies over the years, in­clud­ing Lig­and Phar­ma­ceu­ti­cals, Syn­dax and more re­cent­ly San …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times